Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

6505--Ticagrelor Tablets

Active
36E79726R0028Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.

General Info

VA seeks Ticagrelor Tablets in two packaging groups via unrestricted solicitation, lowest-priced technically acceptable bid wins.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(1)

36E79726R0028_1.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressHINES, IL, 60141, USA
Contacts
Contract SpecialistKenneth Lay

Full Description

Show more
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0028 for an unrestricted procurement for Ticagrelor Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The procurement is structured into two separate groups: Group I includes both 60-count bottles and bulk (500 or 1,000 count) bottles, and Group II includes only 60-count bottles. In order for an offer to be considered, the offeror would be required to include all line items within their offered group. The Government will evaluate each group independently, and only one group will be awarded. Award will be made to the lowest-priced, technically acceptable offeror based on the total evaluated price. The requirements for both groups equate to the same number of tablets for each strength. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. Group I (line items 1 and 3) and Group II (line items 1 and 2) are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (e.g., 60 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0028 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 18, 2026, with a tentative closing date of September 1, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay. Questions can be e-mailed to Kenneth.Lay@va.gov. The estimated annual requirements are as follows:



REQUIREMENT DESCRIPTION GROUP I ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 TICAGRELOR 60MG TAB 60 21,137 2a TICAGRELOR 60MG TAB 500 3,732
OR OR OR 2b TICAGRELOR 60MG TAB 1,000 1,866 3 TICAGRELOR 90MG TAB 60 141,992 4a TICAGRELOR 90MG TAB 500 7,680
OR OR OR 4b TICAGRELOR 90MG TAB 1,000 3,840

GROUP II 1 TICAGRELOR 60MG TAB 60 52,237 2 TICAGRELOR 90MG TAB 60 205,992

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
Azithromycin Tablets Solicitation
Solicitation # SPE2D2-26-R-0008
The solicitation SPE2D2-26-R-0008 for Azithromycin Tablets is a Lowest Price Technically Acceptable (LPTA) acquisition issued by the Defense Logistics Agency under the Department of Defense, targeting pharmaceutical suppliers to provide specified tablet formulations in unit-of-use packaging meeting stringent regulatory and technical standards. The contract encompasses five clinical line items for 250mg, 500mg, and 600mg azithromycin tablets in 6-count, 3-count, and 30-count bottles, with base quantities for each and four one-year option periods allowing for a potential five-year contract duration. Technical acceptability is strictly gated by compliance with current Good Manufacturing Practices, FDA licensing through an approved NDA, ANDA, or BLA, therapeutic equivalence “A” ratings, adherence to the Drug Supply Chain Security Act, and full disclosure of manufacturing facility locations and foreign ownership status. The packaging must be child-proof, cylindrical with minimum dimensional specifications, free of glass, and compatible with automated dispensing systems like Baxter ATC and OptiFill, while requiring GS1-128 or HIBCC barcode labeling at the unit level with NDC, lot number, and expiration date encoded to ANSI/ISO/IEC quality grade C or higher, avoiding barcode placement across perforations or in proximate pairs. Offerors must submit electronic proposals via the DIBBS portal in two volumes—one technical compliance package and one price proposal—with no page limits, but failure to address mandatory representations under FAR 52.204-19, DFARS 252.204-7018, and other referenced clauses results in disqualification. Past performance and technical compliance are evaluated as pass/fail gates before price is considered as the sole award criterion. Delivery is FOB destination to DLA and VA Prime Vendor distribution centers, with performance commencing 45 days after award and pricing effective 15 days after that. Contract payments are routed through Prime Vendor contractors, not directly by the government, and rights to payment cannot be assigned. The closing date has been amended to August 12, 2026, at 3:00 PM EDT, with proposals requiring valid UEI and CAGE codes and certification of small business or other socioeconomic status if applicable. The procurement excludes covered telecommunications equipment and requires full disclosure of country of origin for both active pharmaceutical ingredients and final products, with no tolerance for uncorrected FDA violations
Defense Logistics Agency

POSTED

about 19 hours ago

DEADLINE

in 12 days
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mgThe contract entails the manufacture and supply of 54,000 units of Sumatriptan Succinate 25mg film-coated tablets intended for the acute treatment of migraines, with strict adherence to current Good Manufacturing Practices (cGMP) requirements to ensure product quality, safety, and consistency. The manufacturing process and final product must comply with controlled storage conditions to maintain stability and efficacy throughout the supply chain, reflecting the sensitive nature of pharmaceutical therapeutics. The procurement is structured as a subcontract under the NAICS code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Department of Defense through its Medical Supply Chain Pharm FSA agency, with performance required at Fort Bliss, Texas, 79918-2527. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified suppliers to submit proposals. The contract is not subject to any set-aside provisions and is publicly accessible via the DIBBS platform, suggesting a competitive bidding process open to eligible contractors capable of meeting federal pharmaceutical standards. Compliance with all regulatory, packaging, labeling, and documentation requirements for defense-related medical supplies will be mandatory, and delivery timelines will likely be tied to operational readiness needs of the military healthcare system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Manufacturing and Packaging of Morphine Sulfate InjectionThe contract requires the manufacture, labeling, and packaging of Morphine Sulfate Injection at a concentration of 10mg/mL in 1x10 NEXJECT units, classified as a DEA Schedule II controlled substance, ensuring strict compliance with all applicable federal regulations including those set by the FDA, OSHA, and DLA. The product must adhere to precise quality, safety, and documentation standards appropriate for a high-risk controlled pharmaceutical, with packaging and labeling meeting all regulatory requirements for traceability, security, and handling. The work is to be performed at the designated place of performance in APO with ZIP code 09094-3219, under the oversight of the Department of Defense through the Medical Supply Chain Pharm FSA, and the solicitation is issued as a subcontract with a NAICS code of 325412 for pharmaceutical preparation manufacturing. Responses to this solicitation are due by August 4, 2026, with the opportunity published on July 29, 2026, indicating a limited bid window of one week. All proposals must demonstrate proven capability in handling DEA Schedule II substances, robust quality control systems, validated packaging processes, and full compliance with federal controlled substance handling protocols. The nature of the product and the federal context necessitate secure, auditable manufacturing practices with no tolerance for deviation from regulatory standards, and successful contractors must be equipped to meet the stringent demands of military medical supply chains while maintaining uninterrupted availability of this critical pain management medication.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 541611
New
Federal
Small Business Subcontracting Plan Development & ReportingThe contract requires the development, implementation, and ongoing reporting of a small business subcontracting plan that fully complies with Veterans Affairs guidelines, using the electronic Subcontracting Reporting System eSRS. The work must be performed in alignment with the NAICS code 541611, which pertains to management consulting services, and the plan must be designed to meet federal obligations for small business participation under VA procurement regulations. The contractor will be responsible for ensuring accurate data submission, proper classification of subcontractor types, and adherence to all VA-specific reporting standards throughout the duration of the project. The solicitation is issued under the Department of Veterans Affairs through Nac Pharmaceuticals and has a response deadline of August 13, 2026, with the opportunity posted on July 28, 2026. There is no specified set-aside type, and the place of performance and point of contact details are not provided. The contractor must be prepared to operate within the VA’s compliance framework, maintain transparent records of small business subcontracting efforts, and generate regular, auditable reports through eSRS to demonstrate progress and adherence to federal goals for small business inclusion. The successful bidder will need expertise in federal subcontracting compliance, experience with VA systems and reporting protocols, and a thorough understanding of eSRS workflows and deadlines.
Administrative Management and General Management Consulting Services

POSTED

3 days ago

DEADLINE

in 14 days
View Details